metricas
covid
Medicina Clínica (English Edition) Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure pr...
Journal Information

Statistics

Follow this link to access the full text of the article

Scientific letter
Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
Seguridad e inmunogenicidad de cilgavimab-tixagevimab para la profilaxis preexposición frente a la COVID-19 en pacientes inmunodeprimidos
María Fernández-Pradaa,
Corresponding author
mariafdezprada@gmail.com

Corresponding author.
, Jaime Jesús Pérez-Martínb, Paula Cienfuegos-Gonzáleza
a Servicio de Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Mieres, Asturias, Spain
b Subdirector General de Salud Pública, Consejería de Salud de la Región de Murcia, Murcia, Spain
Read
86
Times
was read the article
0
Total PDF
86
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 10 5 0 5
2025 9 4 0 4
2025 8 9 0 9
2025 7 8 0 8
2025 6 2 0 2
2025 5 8 0 8
2025 4 4 0 4
2025 3 5 0 5
2025 2 1 0 1
2025 1 2 0 2
2024 12 1 0 1
2024 11 3 0 3
2024 10 1 0 1
2024 9 4 0 4
2024 8 3 0 3
2024 7 5 0 5
2024 6 6 0 6
2024 5 8 0 8
2024 4 3 0 3
2024 3 2 0 2
2024 2 1 0 1
2023 12 1 0 1
Show all

Follow this link to access the full text of the article